Renate & Hans Schleussner Award

Terms and Conditions

Terms and Conditions

1. Introduction

These terms and conditions (the "T&Cs") are intended to govern the operation of the Renate & Hans Schleussner Award organized by Biotest AG, a company duly incorporated under German law, with the headquarters at Landsteinerstraße 5, 63303 Dreieich, Germany ("Biotest").

The Renate & Hans Schleussner Award aims to identify, promote and support the realization of innovative clinical and scientific work that offers a greater insight into immunological effects of polyvalent immunoglobulins (IgG, IgA and IgM).

The Renate & Hans Schleussner Award will be assigned for a clinical or preclinical project and is endowed with € 50,000.

These T&Cs are available for consultation on www.biotest.com (the "Website").

2. Participants

Participation in the Renate & Hans Schleussner Award is voluntary and free of charge.

The Participants in the Renate & Hans Schleussner Award may present their proposal individually or as a part of a team. Both individual participants and team participants are jointly referred to as the "Participants".

Participants must meet the following eligibility requirements:

  • present an original research contribution to  basic or clinical research for immunological effects of polyvalent immunoglobulins (IgG, IgA and IgM) that fulfills the requirements set out in Section 4.1.
  • be a scientist or clinician conducting research at a hospital, university or independent institution
  • be employed or supported by a hospital, university or independent institution (the "Institution"), and
  • sign a contract with the Institution and Biotest (the "Contract") if he/she becomes a selected awardee (as such term is defined below).

None of Biotest' and/or its group companies' employees or any relative up to the second degree of kinship of the persons directly involved in the management of Biotest' scientific awards or in the awardee selection process shall be eligible to participate in the Renate & Hans Schleussner Award.

Unless specifically noted in these T&Cs, Biotest will in no case bear any costs and/or expenses incurred by participants as a result of their participation in the Renate & Hans Schleußner Award.

Submissions from awardees of previous editions of the Renate & Hans Schleussner Award will not be accepted.

3. Period of participation and timeline

The period of participation for the Renate & Hans Schleussner Award will commence in August and will finish in the next year at June. For further details, see the Application steps.

4. Award details

Applicants (either individual Participants or the Participant in a team designated to present the proposal) should submit a cover letter, complete the Project Concept (PC) and submit it, together with a short curriculum vitae of all Participants and a protocol summary of the research project (as such term is defined below) according to the terms mentioned in Section 3.

After the deadline for submission of the Project Concept, an independent jury composed of external scientists (e.g. immunologists) and Biotest scientists, whose identity will be published on the Website (the "Jury"), will select a maximum of four (4) research project proposals that best match the requirements described in Section 4.1, taking into consideration the appraisal criteria described in Section 4.2.

The Participants shortlisted by the Jury will be invited to submit a complete research project proposal, following the requirements set forth in Section 4.1.

The participant whose research project (basic research project or clinical research project) is awarded (the "Awardee") will be announced on the website with the name, last name, job position, designation of workplace, and  a brief description of the research project.

The awardee is required to attend the award ceremony in order to receive the award. All costs and/or expenses associated with the awardee's participation in the Award Ceremony will be borne by Biotest. If the awardee or the awardee’s institutions have already made the payment, they will be reimbursed by Biotest after Biotest will receive evidence of the costs and/or expenses incurred in any case subject according to local laws and regulations.

Participants must provide all information requested as part of the selection process in English using the form or documents provided by Biotest, when they are made available.

4.1 Requirements of the Research Projects

Participants must present an innovative basic or clinical research project regarding immunological effects of polyvalent immunoglobulins (IgG, IgA and IgM), which meet the following requirements (the "Research Project"):

(a) Goals should be achieved within a maximum of twenty four (24) months from the award assignment, when the participants is selected as awardee.

(b) The research projects should be related to the immunological effects of polyvalent immunoglobulins (IgG, IgA and IgM).

(c) Studies sponsored by industry are excluded.

(d) Basic research projects may include preclinical animal studies as well as in vitro studies.

(e) Clinical research projects may include any studies requiring patient informed consent, including treatment of patients and/or use of patient samples (e.g. for biomarker analysis, genotyping and diagnostics). 

(f) In no case, submitted research projects shall include any information or data, which directly or indirectly allows the identification of patients and/or any other individuals who are not members of the participant's team and/or the institution

(g) The awardee agrees to submit an interim study report to Biotest after half-time and a full report (the "Final Report") after completion of the research project.

4.2 Appraisal criteria

The research projects will be assessed by the jury taking into account the following criteria:

(a) Scientific merit, which will take into account (i) the validity of the rationale and/or proposed methodology, (ii) the validity of the expected outcomes, (iii) the validity of the proposed timelines, and (iv) the feasibility of completing the proposed research within a maximum term of twenty four (24) months from the award assignment, in case the participants become selected as awardee (max. 2 points).

(b) Innovation of the research project in design, methodology and objectives (max. 2 points).

(c) Clinical/medical impact, which will take into account (i) the contribution of the research project results to clinical and scientific understanding, and (ii) the relevance of the research project in the respective treatment community (max. 2 points).

(d) Mentor and research environment, which will take into account (i) mentor's research focus, clinical/scientific expertise and experience, (ii) qualification of the participants, and (iii) expertise in the academic research environment (max. 2 points). 

5. Award

The selected research project will be awarded with an amount of  Euro 50, 000 (the "Award"). The payment will be made by Biotest to the awarded institution according to the following schedule and mode:

35 % (gross amount) within thirty (30) days of receipt of the corresponding invoice issued by the Institution upon conclusion of the contract.

35 % within thirty (30) days of after receipt of the interim report or documentation of the agreed milestone  at Biotest together with the corresponding invoice issued by the institution.

30 % within thirty (30) days of receipt by Biotest of the Final Report, together with the corresponding invoice issued by the institution.

The awardee acknowledges that Biotest will not transfer any payment of the award directly to him/her.

6. Representations and Warranties. Intellectual and Industrial Property

The participants represent and warrant that (a) they are the scientists or clinician responsible for the submitted research project, (b) any submitted documents and/or information provided are accurate and updated, (c) the research project is an original creation, (d) they have obtained all necessary approvals from the Institution to participate in the Renate & Hans Schleussner Award and their participation do not violate any duty owed to the Institution or any other third party, (e) if applicable, they will obtain the informed consent of the patients in accordance with applicable law, (f) the research project complies with all applicable health regulations, and (g) their participation in the Renate & Hans Schleussner Award and the exercise of the rights licensed by Biotest do not infringe any legal provisions, agreements, rights or assets of  any third party. The Institution will be the exclusive owner of the economic rights of intellectual and industrial property over the research project. By participating in the Renate & Hans Schleussner Award, Biotest is granted a worldwide, non-exclusive, non-transferable (except to Biotest' group companies) royalty free license to use any and all results derived, directly or indirectly, from the research project for Biotest' internal research and development purposes. The awardee shall present any information, data and/or results derived from the research project only with the prior written consent of Biotest, which consent shall not be unreasonably withheld.

7. Data Protection

Any personal data provided by the Participants will be processed in accordance with the Renate & Hans Schleussner Award.

8. Applicable Law and Jurisdiction

These T&Cs are governed by German law.

If any disputes arise from the interpretation and/or execution of the provisions regulated in these T&Cs, the parties will try to resolve these disputes amicably. If the dispute, controversy or difference cannot be amicably resolved, the parties shall submit the dispute, controversy or difference exclusively to the courts of the city of Frankfurt, Germany.

9. General

Participation in the Renate & Hans Schleussner Award implies full and complete acceptance of these T&Cs by each participant. Any statement to the contrary such as not agreeing to the T&Cs, will result in the exclusion of the participant. In this case as a result, Biotest will be released from fulfilling any obligations with respect to said participants.

It is hereby acknowledged that the award granted is not conditioned upon any promotion, prescription and/or use of any products commercialized by Biotest nor it is intended to influence the awardee and the institution to do so.

Biotest reserves the right to cancel the Renate & Hans Schleussner Award at any time on grounds of force majeure, lack of participation or for any other valid reason.

Biotest reserves the right to disqualify any Participant who infringes any of the provisions regulated in these T&Cs and/or any applicable regulation.

Biotest reserves the right to modify these T&Cs if any irregularity is detected that might influence the objectivity and transparency of the Renate & Hans Schleussner Award.

Data Protection Notice

We attach great importance to the protection of your privacy.

This Data Protection Notice explains how and for what purposes Biotest uses your personal data in accordance with the Renate & Hans Schleussner Award and which rights and options you have in this respect.

Who is responsible for your personal data

Biotest AG, Landsteinerstraße 5, 63303 Dreieich, Germany, is responsible for all personal data that you provide to us in the context of  the participation in the application procedure for the  Renate & Hans Schleussner Award.

Categories of personal data collected by us

We collect and process the following categories of personal data in particular:

  • Applicant name, gender, institution name
  • CV
  • Contact details (e-mail address, telephone and address of the Institution)

For which Purpose we use your personal data

We will only process your personal data for the following purposes ("Permitted Purposes"):

  • For the applicant selection, to award the most suitable project.

How we collect and use your personal data                                                                               

We will typically collect your personal data directly from you when you interact with us, e.g. when you forward your application to us, communicate with us in relation to the participation in the selection procedure for the Renate & Hans Schleussner Award.

Where we process your personal data

Biotest is a globally operating enterprise. In the course of our business activities, we may transfer your personal data also to recipients in countries outside the European Economic Area (“third countries”), in which applicable laws do not offer the same level of data protection as the laws of your home country. When doing so we will comply with applicable data protection requirements and take appropriate safeguards to ensure the security and integrity of your personal data, in particular by entering into the EU Standard Contractual Clauses that are available under Standard Contractual Clauses. You may contact us any time using the contact details below if you would like further information on such safeguards.

How we protect your personal data

We maintain physical, electronic and procedural safeguards in accordance with the technical state of the art and legal data protection requirements to protect your personal data. These safeguards include implementing specific technologies and procedures designed to protect your privacy, such as secure servers, firewalls and SSL encryption. We will at all times comply with applicable laws and regulations regarding the confidentiality and security of personal data.

Who we share your personal data with

We may share your personal data as follows:

  • With the members of the Jury. Members are Biotest staff and external scientists.
  • We may also instruct service providers (so called data processors) within or outside of Biotest Group, domestically or abroad (e.g. shared service centers or cloud providers), to process personal data for the Permitted Purposes on our behalf and in accordance with our instructions only. Biotest will retain control over, will remain fully responsible for your personal data, and will use appropriate safeguards as required by applicable law to ensure the integrity and security of your personal data when engaging such service providers.

How long we store your personal data

We will store your data collected during the application for the Renate & Hans Schleussner Award for 3 years.

Your Rights                                                                                         

Subject to certain legal conditions, you may request access to, rectification, erasure or restriction of processing of your personal data. You may also object to processing or request data portability. In particular, you have the right to request a copy of the personal data that we hold about you. If you make this request repeatedly, we may make a charge for this. Please refer to Articles 15-22 of the EU General Data Protection Regulation for details on your data protection rights.

If you have given us your consent for the processing of your personal data, you can withdraw your consent at any time with future effect, i.e. the withdrawal of the consent does not affect the lawfulness of processing based on the consent before its withdrawal. In case consent is withdrawn, we may only further process the personal data where there is another legal ground for the processing or we are legally obliged to do so.

For any of the above requests, please send a brief description of your personal data concerned stating your name, customer number or other identification number (if applicable) as proof of identity to the contact address below or by email to datenschutz@biotest.com. We may require additional proof of identity to protect your personal data against un-authorized access. We will carefully consider your request and may discuss with you how it can best be fulfilled.

If you have any concerns about how your personal data is handled by us or wish to raise a complaint on how we have handled your personal data, you can contact us at:

Biotest AG
Data Protection Officer
Landsteinerstr. 3-5
63303 Dreieich, Germany
or by email at: datenschutz@biotest.com

If you are not satisfied with our response or believe, we are processing your personal data not in accordance with the law you can complain to the competent data protection supervisory authority in your country.

Further information

Further information on data protection at Biotest is available at: